l1orxu

SURVEILLANCE REPORT
Tuberculosis surveillance and monitoring in Europe 2017
Azerbaijan
Population estimate 2015 by UN Statistical Database: 9 753 968
Tuberculosis case notifications, 2015
Total number of cases 7501
Notification rate per 100 000 76.9
New* & relapses 5 46+
New* & relapses notification rate
per 100000
55.9
Pulmonary 5 846 (77.9%)
of which smear positive – –
of which laboratory confirmed 4 010 (68.6%)
Laboratory-confirmed TB cases – –
Mean age of new and relapse TB cases
36.6 years
Mean age of new foreign TB cases
years
Foreign origin of all TB cases 15 (0.2%)
New (not previously treated) 3 989 (53.2%)
* Cases with unknown previous treatment included in new cases.
Drug resistance surveillance & TB-HIV
co-infection, 2015
Completeness of DRS data*
Yes
Completeness of HIV data**
Yes
Case-linked data reporting
Yes
Cases with DST results 3 617 (90.2%)
Estimated MDR N, (best–low–high) 1 400–1 100–1 600
Pulmonary MDR TB cases notified 906 (22.6%)
of which XDR TB cases 125 (18.7%)
TB cases tested for HIV 6 964 (92.8%)
HIV-positive TB cases 112 (1.6%)
of these on antiretroviral therapy 89 (79.5%)
* National coverage 100% or culturing 90%. C+/All TB
cases 50%. DST done for C+ 75%. EQA 95%.
** More than 50% of TB cases tested for HIV.
Treatment outcome monitoring
Geographical
coverage
Outcome cohort
National
Bacteriologically
confirmed new TB
cases in 2014*
All MDR TB cases
enrolled into MDR
treatment in 2013**
Case-linked data
reporting
Yes
Cases notified 1 623 647
Success 1 349 (83.1%) 382 (59.0%)
Died 55 (3.4%) 111 (17.2%)
Failed 46 (2.8%) 118 (18.2%)
Lost to follow-up 127 (7.8%) 36 (5.6%)
Not evaluated 46 (2.8%) 0 (0.0%)
* Treatment outcome as presented is treatment outcome after 12 months.
** Treatment outcome as presented is treatment outcome after 24 months.
Tuberculosis notification rates by treatment history, 2006–2015*
Cases / 100 000
120
100
80
60
40
20
0
2006
New & relapses
Other retreatment
2008
2010
Unknown
Total
2012
2014
New and relapsed TB cases – notification rates by age group,
2006–2015*
Cases / 100 000
80
70
60
50
40
30
20
10
0
2006
* Starting from 2013 onward cases with unknown history are included in new and relapses. * Data up to 2012 includes new TB cases only.
0–14
2008
15–44
2010
45–64
2012
2014
>64
Tuberculosis cases by geographical origin, 2006–2015
TB-HIV co-infection, 2006–2015
10000
Native
Foreign origin
Unknown
100
HIV testing coverage TB cases*
Proportion of HIV positive TB cases among tested
12000
No. of cases
8000
6000
4000
2000
Percentage
80
60
40
20
10000
8000
6000
4000
2000
No. of cases
0
2006
2008
2010
2012
2014
0
2006
2008
2010
2012
2014
0
* Since 2015 data on HIV detection are collected for new TB cases and relapses.
MDR TB cases by previous treatment history, 2006–2015 Treatment outcome of new TB cases, 2005–2014
Percentage
90
80
70
60
50
40
30
20
10
0
2006
New
Retreatment
Total number of MDR TB
2008 2010 2012
Unknown
1200
1000
800
600
400
200
0
2014
No. of cases
Percentage
100
80
60
40
20
0
2005
Success
Died
2007
Failed Not evaluated
Lost to follow up
2009
2011
2013
105